-
Participants in the Framingham Heart Study who had low levels of cardiovascular risk factors in middle age had longer overall survival and less morbidity when followed to age 85. Control of risk factors may have a major influence on reaching older age in good health.
-
The FDA has approved a new drug for the treatment of gastrointestinal stromal tumor and metastatic renal cell cancer. Sunitinib is an orally active, highly selective, multi-targeted tyrosine kinase inhibitor. The drug was given a priority review and was approved in less than 6 months. Sunitinib is marketed by Pfizer as Sutent®.
-
Erectile Dysfunction and Subsequent Cardiovascular Disease; Oseltamivir Resistance during Influenza A Infection; Dietary Intake of Antioxidants and AMD
-
-
-
Can Calcium and Vitamin D Prevent Hip Fractures?; Treatment of Benign Prostatic Hyperplasia; Treatment of Osteoarthritis of the Knee; Refractory Asthma and TNFConnection?; FDA Actions
-
Cardiovascular disease affects 25% of the U.S. population. It is responsible for more than 1 million deaths each year, which makes it the number one killer in the United States. Fifty percent of men and 64% of women who suffer from sudden cardiac death have no previous history or symptoms of heart disease.
-
-
Researchers created a simple, three-visit intervention to assist caregivers of cancer patients who are in hospice because of advanced cancer.
-
When the West Virginia School of Nursing needed a new instructor for its parish nursing Internet class, the woman who had been teaching the course approached two officials with Hospice Care Corp. of Arthurdale, WV.
